Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ITCI - Intra-Cellular Therapies, Inc.
528 K
LAST VALUE
-0.50%
2 YEAR CAGR
7.45%
5 YEAR CAGR
36.65%
10 YEAR CAGR